Grace Capital Stock from 2010 to 2024
| GRCE Stock | 3.44 0.16 4.88% |
Capital Stock | First Reported 2010-12-31 | Previous Quarter 261 M | Current Value 268 M | Quarterly Volatility 29.4 M |
Check Grace Therapeutics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Grace Therapeutics,'s main balance sheet or income statement drivers, such as Net Interest Income of 956.5 K, Interest Income of 956.5 K or Interest Expense of 0.0, as well as many indicators such as . Grace financial statements analysis is a perfect complement when working with Grace Therapeutics, Valuation or Volatility modules.
Grace | Capital Stock |
Latest Grace Therapeutics,'s Capital Stock Growth Pattern
Below is the plot of the Capital Stock of Grace Therapeutics, over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Grace Therapeutics,'s Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Grace Therapeutics,'s overall financial position and show how it may be relating to other accounts over time.
| Capital Stock | 10 Years Trend |
|
Capital Stock |
| Timeline |
Grace Capital Stock Regression Statistics
| Arithmetic Mean | 214,296,527 | |
| Geometric Mean | 212,564,899 | |
| Coefficient Of Variation | 13.74 | |
| Mean Deviation | 25,083,706 | |
| Median | 197,194,000 | |
| Standard Deviation | 29,435,543 | |
| Sample Variance | 866.5T | |
| Range | 70.8M | |
| R-Value | 0.77 | |
| Mean Square Error | 373.4T | |
| R-Squared | 0.60 | |
| Significance | 0.0007 | |
| Slope | 5,097,619 | |
| Total Sum of Squares | 12130.3T |
Grace Capital Stock History
Other Fundumenentals of Grace Therapeutics,
Grace Therapeutics, Capital Stock component correlations
Click cells to compare fundamentals
About Grace Therapeutics, Financial Statements
Grace Therapeutics, stakeholders use historical fundamental indicators, such as Grace Therapeutics,'s Capital Stock, to determine how well the company is positioned to perform in the future. Although Grace Therapeutics, investors may analyze each financial statement separately, they are all interrelated. For example, changes in Grace Therapeutics,'s assets and liabilities are reflected in the revenues and expenses on Grace Therapeutics,'s income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Grace Therapeutics,. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capital Stock | 261 M | 268 M | |
| Issuance Of Capital Stock | 7.3 M | 13.4 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Grace Therapeutics, is a strong investment it is important to analyze Grace Therapeutics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Grace Therapeutics,'s future performance. For an informed investment choice regarding Grace Stock, refer to the following important reports:Check out the analysis of Grace Therapeutics, Correlation against competitors. For information on how to trade Grace Stock refer to our How to Trade Grace Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Grace Therapeutics,. If investors know Grace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Grace Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Grace Therapeutics, is measured differently than its book value, which is the value of Grace that is recorded on the company's balance sheet. Investors also form their own opinion of Grace Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Grace Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Grace Therapeutics,'s market value can be influenced by many factors that don't directly affect Grace Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Grace Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Grace Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Grace Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.